1. Home
  2. PRQR vs BEBE Comparison

PRQR vs BEBE Comparison

Compare PRQR & BEBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.48

Market Cap

167.5M

Sector

Health Care

ML Signal

HOLD

BEBE

TGE Value Creative Solutions Corp Class A Ordinary Shares

N/A

Current Price

$9.88

Market Cap

197.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PRQR
BEBE
Founded
2012
2025
Country
Netherlands
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.5M
197.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PRQR
BEBE
Price
$1.48
$9.88
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$6.80
N/A
AVG Volume (30 Days)
291.4K
7.3K
Earning Date
03-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.88
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$9.81
52 Week High
$3.10
$9.95

Technical Indicators

Market Signals
Indicator
PRQR
BEBE
Relative Strength Index (RSI) 43.57 60.47
Support Level $1.33 $9.87
Resistance Level $1.58 $9.94
Average True Range (ATR) 0.12 0.00
MACD -0.03 -0.00
Stochastic Oscillator 26.00 12.50

Price Performance

Historical Comparison
PRQR
BEBE

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

About BEBE TGE Value Creative Solutions Corp Class A Ordinary Shares

TGE Value Creative Solutions Corp is a blank check company.

Share on Social Networks: